Search





Search





Markets
/
Stocks
/
bolt
/

Bolt Biotherapeutics Inc

BOLT

Add to Watchlist

3.990USD

+0.100+2.57%

Close 07-31 16:00（ET）Quotes delayed by 15 min

7.66MMarket Cap

LossP/E TTM

Bolt Biotherapeutics Inc

3.990

+0.100+2.57%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

BOLT Cash Flow Statement

You can access the annual and quarterly cash flow statements of Bolt Biotherapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

39.97%-8.02M

50.41%-7.16M

30.32%-9.73M

40.55%-9.60M

20.21%-13.37M

-1.16%-14.43M

16.62%-13.97M

-6.82%-16.14M

28.41%-16.75M

20.54%-14.27M

-24.52%-16.75M

27.30%-15.11M

3.76%-23.40M

-0.89%-17.95M

28.17%-13.45M

-421.50%-20.79M

-46.83%-24.31M

-38.04%-17.79M

-49.64%-18.73M

67.50%-3.99M

-71.81%-16.56M

-105.84%-12.89M

-51.11%-12.52M

---12.27M

---9.64M

---6.26M

---8.28M

Net income from continuing operations

34.38%-7.24M

58.39%-6.63M

52.93%-7.14M

59.61%-8.56M

-2.12%-11.04M

10.99%-15.94M

6.65%-15.18M

-17.38%-21.20M

36.33%-10.81M

10.47%-17.90M

25.29%-16.26M

20.33%-18.06M

28.29%-16.98M

26.37%-20.00M

6.99%-21.76M

3.91%-22.66M

3.17%-23.68M

12.50%-27.16M

-133.93%-23.39M

-113.27%-23.59M

-183.26%-24.45M

-231.50%-31.04M

-39.21%-10.00M

---11.06M

---8.63M

---9.36M

---7.18M

Operating gains losses

-49.12%203.00K

-86.54%255.00K

-34.09%290.00K

-24.07%347.00K

-12.88%399.00K

305.78%1.90M

-4.76%440.00K

-0.22%457.00K

-1.93%458.00K

1.08%467.00K

5.24%462.00K

12.25%458.00K

30.81%467.00K

27.98%462.00K

44.41%439.00K

59.38%408.00K

31.25%357.00K

63.35%361.00K

69.83%304.00K

132.73%256.00K

169.31%272.00K

130.21%221.00K

110.59%179.00K

--110.00K

--101.00K

--96.00K

--85.00K

Other non-cash items

52.96%621.00K

230.67%490.00K

58.13%506.00K

15233.33%454.00K

256.15%406.00K

13.99%-375.00K

154.15%320.00K

99.21%-3.00K

-95.49%-260.00K

-286.32%-436.00K

-191.77%-591.00K

-142.62%-381.00K

-108.12%-133.00K

-82.86%234.00K

-59.32%644.00K

-35.40%894.00K

-76.22%1.64M

-90.73%1.36M

184.11%1.58M

214.55%1.38M

1651.91%6.88M

3473.06%14.72M

-622.78%-1.88M

--440.00K

--393.00K

--412.00K

--360.00K

Change in working capital

40.38%-2.12M

-93.23%-2.31M

-555.88%-3.79M

-238.78%-2.46M

57.93%-3.55M

-177.71%-1.20M

78.53%-578.00K

242.47%1.77M

8.55%-8.44M

298.84%1.54M

-152.97%-2.69M

128.52%518.00K

-66.32%-9.23M

-114.37%-774.00K

815.68%5.08M

-111.40%-1.82M

-304.74%-5.55M

104.52%5.39M

145.72%555.00K

905.26%15.94M

20.48%-1.37M

13.58%2.63M

25.52%-1.21M

---1.98M

---1.72M

--2.32M

---1.63M

-Change in prepaid expenses

53.25%-79.00K

430.67%398.00K

-121.61%-86.00K

-103.01%-67.00K

-30.00%-169.00K

-95.70%75.00K

131.34%398.00K

396.21%2.23M

90.56%-130.00K

1017.89%1.74M

-203.42%-1.27M

150.84%449.00K

35.05%-1.38M

-102.87%-190.00K

118.73%1.23M

-75.10%179.00K

-56.92%-2.12M

2081.74%6.62M

-464.11%-6.55M

273.25%719.00K

-4193.94%-1.35M

-139.11%-334.00K

-79.32%-1.16M

---415.00K

--33.00K

--854.00K

---648.00K

-Change in payables and accrued expense

44.13%-1.40M

92.70%-197.00K

-523.87%-1.88M

-191.80%-840.00K

29.15%-2.51M

-327.10%-2.70M

-46.31%444.00K

-22.65%915.00K

46.39%-3.54M

313.94%1.19M

-85.15%827.00K

270.22%1.18M

-176.38%-6.61M

152.28%287.00K

78.75%5.57M

-116.56%-695.00K

-2618.18%-2.39M

-117.69%-549.00K

1335.48%3.12M

4015.69%4.20M

83.70%-88.00K

76.71%3.10M

128.48%217.00K

--102.00K

---540.00K

--1.76M

---762.00K

-Change in other current liabilities

104.04%15.00K

-336.01%-1.88M

-74.08%-1.23M

-48.48%-1.03M

90.98%-371.00K

205.56%797.00K

56.79%-706.00K

-29.78%-693.00K

-503.23%-4.11M

-213.28%-755.00K

-35.15%-1.63M

34.96%-534.00K

-1140.00%-682.00K

28.06%-241.00K

-126.58%-1.21M

-107.23%-821.00K

-2850.00%-55.00K

-11266.67%-335.00K

2724.84%4.55M

16810.29%11.36M

-66.67%2.00K

-98.47%3.00K

287.21%161.00K

---68.00K

--6.00K

--196.00K

---86.00K

Cash from non-recurring investing activities

Cash from operating activities

39.97%-8.02M

50.41%-7.16M

30.32%-9.73M

40.55%-9.60M

20.21%-13.37M

-1.16%-14.43M

16.62%-13.97M

-6.82%-16.14M

28.41%-16.75M

20.54%-14.27M

-24.52%-16.75M

27.30%-15.11M

3.76%-23.40M

-0.89%-17.95M

28.17%-13.45M

-421.50%-20.79M

-46.83%-24.31M

-38.04%-17.79M

-49.64%-18.73M

67.50%-3.99M

-71.81%-16.56M

-105.84%-12.89M

-51.11%-12.52M

---12.27M

---9.64M

---6.26M

---8.28M

Investing cash flow

Net cash from continuing investing activities

96.78%-31.00K

--0.00

167.29%72.00K

--0.00

---963.00K

-100.00%0.00

-164.85%-107.00K

-100.00%0.00

-96.74%6.00K

-77.55%165.00K

-92.54%32.00K

-99.50%3.00K

-67.26%184.00K

-27.59%735.00K

-38.98%429.00K

943.10%605.00K

-37.42%562.00K

-11.82%1.01M

-16.31%703.00K

-84.45%58.00K

1240.30%898.00K

381.59%1.15M

--840.00K

--373.00K

--67.00K

--239.00K

Capital expenditures

----

--0.00

75.61%72.00K

----

-100.00%0.00

-75.15%41.00K

-100.00%0.00

-96.74%6.00K

-77.55%165.00K

-92.54%32.00K

-99.50%3.00K

-67.26%184.00K

-27.59%735.00K

-38.98%429.00K

943.10%605.00K

-37.42%562.00K

-11.82%1.01M

-16.31%703.00K

-84.45%58.00K

1240.30%898.00K

381.59%1.15M

--840.00K

--373.00K

--67.00K

--239.00K

Net cash flow from disposal of fixed assets

96.78%-31.00K

--0.00

167.29%72.00K

--0.00

---963.00K

-100.00%0.00

-164.85%-107.00K

-100.00%0.00

-96.74%6.00K

-77.55%165.00K

-92.54%32.00K

-99.50%3.00K

-67.26%184.00K

-27.59%735.00K

-38.98%429.00K

943.10%605.00K

-37.42%562.00K

-11.82%1.01M

-16.31%703.00K

-84.45%58.00K

1240.30%898.00K

381.59%1.15M

--840.00K

--373.00K

--67.00K

--239.00K

Net cash flow from investment products

-41.92%7.89M

-91.22%1.07M

5.43%17.96M

-40.05%10.79M

33.18%13.59M

-22.66%12.23M

32.82%17.03M

32.26%18.00M

-64.81%10.20M

-4.84%15.81M

486.86%12.82M

3200.68%13.61M

-30.05%28.99M

-23.04%16.62M

114.47%2.19M

99.04%-439.00K

121.76%41.45M

729.94%21.59M

-26.39%-15.10M

-974.77%-45.90M

-1339.09%-190.46M

--2.60M

---11.94M

--5.25M

---13.23M

--0.00

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-45.55%7.92M

-91.22%1.07M

4.35%17.88M

-40.05%10.79M

42.61%14.55M

-22.63%12.23M

35.39%17.14M

32.57%18.00M

-64.81%10.20M

-3.81%15.81M

772.97%12.66M

1664.52%13.58M

-29.02%28.99M

-21.86%16.43M

109.00%1.45M

98.14%-868.00K

121.44%40.84M

1134.33%21.03M

-23.03%-16.11M

-1157.45%-46.60M

-1300.07%-190.52M

2643.28%1.70M

-5379.08%-13.10M

--4.41M

---13.61M

---67.00K

---239.00K

Financing cash flow

Cash flow from continuous financing activities

--6.00K

-82.76%5.00K

--0.00

-82.28%14.00K

--0.00

-72.64%29.00K

--0.00

-46.26%79.00K

----

-26.39%106.00K

--0.00

-41.67%147.00K

-100.00%0.00

-70.91%144.00K

-100.00%0.00

-98.12%252.00K

-99.96%107.00K

146.48%495.00K

120.04%185.00K

-67.73%13.41M

873485.29%297.02M

-4196.15%-1.06M

-104.12%-923.00K

--41.55M

--34.00K

--26.00K

--22.38M

Net cash flow from debt Issuance/repayment

----

--0.00

100.00%0.00

--0.00

----

--0.00

---21.00K

Net cash flow from common stock issuance/repurchase

--6.00K

-82.76%5.00K

--0.00

-82.28%14.00K

----

-72.64%29.00K

--0.00

-46.26%79.00K

----

-26.39%106.00K

--0.00

-41.67%147.00K

-100.00%0.00

-70.91%144.00K

-100.00%0.00

-98.12%252.00K

-99.96%107.00K

534.62%495.00K

4.52%185.00K

268080.00%13.41M

720832.35%245.12M

200.00%78.00K

--177.00K

--5.00K

--34.00K

--26.00K

--0.00

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

-100.00%0.00

--0.00

--51.90M

----

--0.00

----

Net cash flow from other financing activities

--0.00

----

---1.14M

-104.91%-1.10M

--41.55M

----

--0.00

--22.40M

Net cash from non-recurrent financing activities

Net cash from financing activities

--6.00K

-82.76%5.00K

--0.00

-82.28%14.00K

--0.00

-72.64%29.00K

--0.00

-46.26%79.00K

----

-26.39%106.00K

--0.00

-41.67%147.00K

-100.00%0.00

-70.91%144.00K

-100.00%0.00

-98.12%252.00K

-99.96%107.00K

146.48%495.00K

120.04%185.00K

-67.73%13.41M

873485.29%297.02M

-4196.15%-1.06M

-104.12%-923.00K

--41.55M

--34.00K

--26.00K

--22.38M

Net cash flow

Beginning cash balance

49.84%13.44M

75.22%19.52M

42.66%11.37M

68.51%10.16M

-28.67%8.97M

1.96%11.14M

-46.94%7.97M

-63.25%6.03M

16.34%12.57M

-10.32%10.93M

-37.91%15.02M

-64.02%16.40M

-62.66%10.81M

-51.69%12.18M

-59.61%24.18M

-53.03%45.59M

307.32%28.95M

30.25%25.21M

30.45%59.87M

695.59%97.05M

-79.93%7.11M

-53.59%19.36M

64.73%45.89M

--12.20M

--35.41M

--41.71M

--27.86M

Current period cash flow changes

-107.93%-94.00K

-180.18%-6.08M

157.00%8.15M

-37.63%1.21M

118.11%1.19M

-231.45%-2.17M

177.54%3.17M

240.07%1.94M

-217.10%-6.55M

220.17%1.65M

65.91%-4.09M

93.53%-1.39M

-66.39%5.59M

-136.77%-1.37M

65.37%-12.00M

42.43%-21.40M

-81.50%16.64M

130.48%3.73M

-30.60%-34.65M

-210.35%-37.18M

487.47%89.94M

-94.37%-12.25M

-291.50%-26.53M

--33.69M

---23.21M

---6.30M

--13.86M

Ending cash balance

31.42%13.35M

49.84%13.44M

75.22%19.52M

42.66%11.37M

68.51%10.16M

-28.67%8.97M

1.96%11.14M

-46.94%7.97M

-63.25%6.03M

16.34%12.57M

-10.32%10.93M

-37.91%15.02M

-64.02%16.40M

-62.66%10.81M

-51.69%12.18M

-59.61%24.18M

-53.03%45.59M

307.32%28.95M

30.25%25.21M

30.45%59.87M

695.59%97.05M

-79.93%7.11M

-53.59%19.36M

--45.89M

--12.20M

--35.41M

--41.71M

Free cash flow

39.97%-8.02M

50.41%-7.16M

30.01%-9.80M

40.55%-9.60M

20.21%-13.37M

-1.11%-14.43M

17.19%-14.01M

-6.59%-16.14M

28.42%-16.75M

21.31%-14.27M

-19.23%-16.91M

28.62%-15.14M

6.09%-23.40M

1.20%-18.14M

28.14%-14.19M

-352.46%-21.22M

-49.96%-24.92M

-33.13%-18.36M

-44.46%-19.74M

64.22%-4.69M

-65.99%-16.62M

-117.85%-13.79M

-60.38%-13.67M

---13.11M

---10.01M

---6.33M

---8.52M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Bolt Biotherapeutics Inc Generate?



Bolt Biotherapeutics Inc generated -39.85M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Bolt Biotherapeutics Inc's Operating Cash Flow Change Year Over Year?



Bolt Biotherapeutics Inc's operating cash flow increased by 34.98% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Bolt Biotherapeutics Inc Spend on Capital Expenditures?



Bolt Biotherapeutics Inc spent 72.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Bolt Biotherapeutics Inc's Financing Cash Flow Changed?



Bolt Biotherapeutics Inc used 19.00K in financing activities in the latest quarter.

What is free cash flow and why does it matter for BOLT?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Bolt Biotherapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -39.92M reflecting a 34.91% change from the previous year.